Subgroup analysis based on baseline daily average stool frequency
| Mesalazine (N=57) | Placebo (N=58) | |
|---|---|---|
| Daily mean stool frequency at 11–12 weeks by baseline frequency, mean (SD) | ||
| Baseline frequency ≤2.4 | 1.7 (0.4) | 1.6 (0.5) |
| Baseline frequency >2.4 and ≤3.4 | 2.2 (0.5) | 2.2 (1.1) |
| Baseline frequency >3.4 ≤4.6 | 3.1 (1.3) | 2.7 (0.9) |
| Baseline frequency >4.6 | 4.1 (1.1) | 4.7 (2.9) |